Valuation : Celltrion, Inc.

Market Cap 45,336B 33.11B 28.51B 26.77B 24.43B 45.9B 3,150B 46.23B 317B 123B 1,598B 124B 122B 5,290B P/E 2026 *
28.7x
P/E 2027 * 24.9x
Enterprise Value 47.53B 34.72M 29.89M 28.07M 25.62M 48.13M 3.3B 48.47M 333M 129M 1.67B 130M 128M 5.55B EV / Sales 2026 *
8.67x
EV / Sales 2027 * 7.43x
Free-Float
60.59%
Yield 2026 *
0.4%
Yield 2027 * 0.43%
1 day-0.94%
1 week-1.77%
Current month+1.18%
1 month-0.58%
3 months+2.82%
6 months-16.84%
Current year+9.58%
1 week 185,000
Extreme 185000
195,500
1 month 180,300
Extreme 180300
212,000
Current year 158,500
Extreme 158500
239,047.62
1 year 158,500
Extreme 158500
239,047.62
3 years 114,250.83
Extreme 114250.828535
239,047.62
5 years 114,250.83
Extreme 114250.828535
242,947.28
10 years 64,487.59
Extreme 64487.593381
325,235.48
Manager TitleAgeSince
Chief Executive Officer 65 19/03/2015
Chief Executive Officer 42 25/03/2021
President 50 12/02/2026
Director TitleAgeSince
Chairman 68 -
Director/Board Member 61 31/03/2005
Director/Board Member 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
16/01/26 Sell 500 0.0002%
16/01/26 Sell 1,000 0.0004%
16/01/26 Sell 1,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-1.77%+18.34%+46.84% 33.21B
-1.23%-1.91%+0.98%+17.94% 50.47B
-1.93%-3.76%+415.10%+499.41% 44.56B
-1.17%-0.55%+40.86%+16.26% 43.08B
-2.46%-4.13%+7.40%+71.82% 41.7B
-1.67%-4.27%+25.40%+119.62% 16.77B
+6.39%+4.62% - - 16.28B
+0.25%-0.98%+11.63%+27.62% 14.58B
-1.45%-3.77%+78.19%+38.93% 13.92B
-2.99%-5.03%-7.35%-36.62% 13.12B
Average -0.71%-1.24%+65.62%+89.09% 28.77B
Weighted average by Cap. -1.06%-1.06%+84.05%+113.78%

Financials

2026 *2027 *
Net sales 5,480B 4B 3.45B 3.24B 2.95B 5.55B 381B 5.59B 38.34B 14.92B 193B 15.03B 14.7B 639B 6,294B 4.6B 3.96B 3.72B 3.39B 6.37B 437B 6.42B 44.03B 17.13B 222B 17.26B 16.88B 734B
Net income 1,511B 1.1B 950M 892M 814M 1.53B 105B 1.54B 10.57B 4.11B 53.24B 4.14B 4.05B 176B 1,763B 1.29B 1.11B 1.04B 950M 1.79B 123B 1.8B 12.34B 4.8B 62.14B 4.84B 4.73B 206B
Net Debt 2,199B 1.61B 1.38B 1.3B 1.18B 2.23B 153B 2.24B 15.38B 5.98B 77.47B 6.03B 5.9B 257B 1,409B 1.03B 886M 832M 759M 1.43B 97.91B 1.44B 9.86B 3.84B 49.65B 3.86B 3.78B 164B
Logo Celltrion, Inc.
Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.
Employees
2,956
Date Price Change Volume
30/08/26 188,900.00 -0.94% 606,202
28/08/26 ₩190,700.00 -0.31% 375,920
27/08/26 ₩191,300.00 -1.09% 255,697
26/08/26 ₩193,400.00 +2.00% 326,386
25/08/26 ₩189,600.00 -2.27% 358,412
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
188,900.00KRW
Average target price
266,031.64KRW
Spread / Average Target
+40.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A068270 Stock